HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Left Out Of $80M For Stopping Consumer Product Fraud In Latest US COVID-19 Relief Act

Executive Summary

American Rescue Plan Act appropriated $50m to Consumer Product Safety Commission and $30.4m to Federal Trade Commission for COVID-19-related enforcement. Neither agency received funding for pandemic-related enforcement in previous relief packages.

You may also be interested in...



US COVID-19 Relief Package Boosts Pharma Manufacturing Programs – More To Come?

$10bn here and $6bn there on top of what’s left from earlier CARES Act gives government more options on COVID-19 medical countermeasures.

Congress Gives FDA Authority To Destroy Counterfeit Devices Found In Imports

Safeguarding Therapeutics Act, approved by the House in September and by the Senate on 8 December, targets the proliferation of shipments into the US containing fake testing kits, cures and vaccines that claim to address coronavirus, some available OTC.

COVID-19 False Advertising Symptoms In US Exceed FTC’s Prognosis For Number, Variety

FTC Division of Advertising Practices anticipated surge of false ads for consumer health products related to COVID-19 but it didn’t expect quite the number as well as the variety of bogus claims it’s found, says Assistant Director Richard Cleland.

Related Content

Topics

UsernamePublicRestriction

Register

RS151121

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel